Intellia Therapeutics
NTLA
NTLA
157 hedge funds and large institutions have $833M invested in Intellia Therapeutics in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 53 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.41% more ownership
Funds ownership: 66.97% → 67.37% (+0.41%)
25% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 53
54% less call options, than puts
Call options by funds: $3.02M | Put options by funds: $6.49M
Holders
157
Holding in Top 10
4
Calls
$3.02M
Puts
$6.49M
Top Buyers
| 1 | +$35.5M | |
| 2 | +$8.23M | |
| 3 | +$5.38M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$4.72M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.08M |
Top Sellers
| 1 | -$18M | |
| 2 | -$10.1M | |
| 3 | -$8.3M | |
| 4 |
Morgan Stanley
New York
|
-$7.56M |
| 5 |
AVAI
Atlas Venture Associates IX
Boston,
Massachusetts
|
-$6.34M |